Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsCorrelations

Poseida Therapeutics (PSTX) Income Statement (2020 - 2024)

Income Statement report data from Sep 30, 2020 to Sep 30, 2024 for Poseida Therapeutics (PSTX).

Reported currency: USD
Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Revenue and COGS
Total Revenue
72M
(+176.28%)
26M
(-7.71%)
28M
(+12.56%)
25M
(+167.38%)
9.35M
(-53.27%)
20M
(+93.52%)
10M
(+2.89%)
10M
(-91.36%)
116M
(+4207.78%)
2.70M
(+87.50%)
1.44M------
Gross Profit
72M
(+176.28%)
26M
(-7.71%)
28M
(+12.56%)
25M
(+167.38%)
9.35M
(-53.27%)
20M
(+93.52%)
10M
(+2.89%)
10M
(-91.36%)
116M
(+4207.78%)
2.70M
(+87.50%)
1.44M------
Operating Expenses
Research And Development
42M
(-7.99%)
46M
(+6.13%)
43M
(+2.07%)
42M
(+12.19%)
37M
(-4.36%)
39M
(+3.00%)
38M
(+12.24%)
34M
(-3.53%)
35M
(+0.37%)
35M
(-28.33%)
49M
(+24.90%)
39M
(+20.26%)
33M
(-9.69%)
36M
(+23.75%)
29M
(+4.38%)
28M
(+3.18%)
27M
Selling General And Administrative
10M
(-17.16%)
12M
(+24.29%)
9.80M
(+10.61%)
8.86M
(+9.52%)
8.09M
(-6.80%)
8.68M
(-26.50%)
12M
(+26.04%)
9.37M
(-0.21%)
9.39M
(+1.62%)
9.24M
(-3.25%)
9.55M
(-0.62%)
9.61M
(+5.95%)
9.07M
(+2.25%)
8.87M
(+5.97%)
8.37M
(+11.90%)
7.48M
(+15.79%)
6.46M
Operating Expenses
52M
(-9.91%)
58M
(+9.50%)
53M
(+3.58%)
51M
(+11.70%)
46M
(-4.80%)
48M
(-3.99%)
50M
(+15.23%)
43M
(-2.83%)
45M
(+0.63%)
44M
(-24.23%)
58M
(+19.87%)
49M
(+17.14%)
42M
(-7.33%)
45M
(+19.81%)
37M
(+5.94%)
35M
(+5.65%)
33M
Operating Income
Operating Income
20M-31.76M
(+29.21%)
-24.58M
(-5.13%)
-25.91M
(-28.46%)
-36.22M
(+30.05%)
-27.85M
(-29.53%)
-39.52M
(+18.96%)
-33.22M72M-41.54M
(-27.07%)
-56.96M
(+225.86%)
-17.48M
(-57.97%)
-41.59M
(-7.33%)
-44.88M
(+19.81%)
-37.46M
(+5.94%)
-35.36M
(+5.65%)
-33.47M
EBITDA
21M-30.41M
(+31.08%)
-23.20M
(-5.19%)
-24.47M
(-29.64%)
-34.78M
(+31.54%)
-26.44M
(-30.77%)
-38.19M
(+19.83%)
-31.87M73M-40.28M
(-27.75%)
-55.75M
(+242.02%)
-16.30M
(-59.67%)
-40.42M
(-7.61%)
-43.75M
(+20.23%)
-36.39M
(+6.03%)
-34.32M
(+4.67%)
-32.79M
Other Income / Expenses
Interest Expense
-2.29M
(+1.33%)
-2.26M
(+0.44%)
-2.25M
(-0.88%)
-2.27M
(+1.34%)
-2.24M
(+4.67%)
-2.14M
(+5.42%)
-2.03M
(+3.05%)
-1.97M
(+11.30%)
-1.77M
(+14.94%)
-1.54M
(+42.59%)
-1.08M
(+28.57%)
-840.00K
(0.00%)
-840.00K
(0.00%)
-840.00K
(0.00%)
-840.00K
(-1.18%)
-850.00K
(0.00%)
-850.00K
Net Interest Income
2.30M
(+1.77%)
2.26M
(+0.44%)
2.25M
(-0.88%)
2.27M
(+1.34%)
2.24M
(+4.67%)
2.14M
(+5.42%)
2.03M
(+2.53%)
1.98M
(+11.24%)
1.78M
(+15.58%)
1.54M
(+42.59%)
1.08M
(+28.57%)
840K
(0.00%)
840K
(0.00%)
840K
(0.00%)
840K
(-1.18%)
850K
(0.00%)
850K
Other Non Operating Income
2.83M
(+7.20%)
2.64M
(+3.13%)
2.56M
(-9.54%)
2.83M
(-58.32%)
6.79M
(+167.32%)
2.54M
(-5.93%)
2.70M
(+24.42%)
2.17M
(+228.79%)
660K
(+1220.00%)
50K-20.00K20M-20K-10.00K60K-90.00K
Net Income
Income Before Tax
20M-31.37M
(+29.25%)
-24.27M
(-4.26%)
-25.35M
(-19.96%)
-31.67M
(+15.33%)
-27.46M
(-29.32%)
-38.85M
(+17.62%)
-33.03M71M-43.04M
(-25.87%)
-58.06M1.47M-42.42M
(-7.18%)
-45.70M
(+19.29%)
-38.31M
(+5.98%)
-36.15M
(+5.06%)
-34.41M
Income Tax Expense
40K---110K--290K
(+16.00%)
250K--------
Net Income From Continuing Operations
20M-31.37M
(+29.25%)
-24.27M
(-4.26%)
-25.35M
(-20.23%)
-31.78M
(+15.73%)
-27.46M
(-29.32%)
-38.85M
(+16.60%)
-33.32M70M-43.04M
(-25.87%)
-58.06M1.47M-42.42M
(-7.18%)
-45.70M
(+19.29%)
-38.31M
(+5.98%)
-36.15M
(+5.06%)
-34.41M
Net Income
20M-31.37M
(+29.25%)
-24.27M
(-4.26%)
-25.35M
(-20.23%)
-31.78M
(+15.73%)
-27.46M
(-29.32%)
-38.85M
(+16.60%)
-33.32M70M-43.04M
(-25.87%)
-58.06M1.47M-42.42M
(-7.18%)
-45.70M
(+19.29%)
-38.31M
(+5.98%)
-36.15M
(+5.06%)
-34.41M